|Bid||0.9500 x N/A|
|Ask||0.9700 x N/A|
|Day's Range||0.9600 - 0.9700|
|52 Week Range||0.8600 - 1.7600|
|Beta (5Y Monthly)||1.30|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.25|
Nanalysis Scientific Corp. ("the Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications announces that on Thursday, August 25, 2022, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Interim Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter June 30, 2022.
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO. The Company is pleased that its Corporate Controller, Randall McRae, has been appointed interim-CFO.
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...